chevron_leftBack
As of 24 April 2025, Pulse Biosciences, Inc. has a market cap of $1.22B USD, ranking #7278 globally and #1715 in the United States. It ranks #690 in the Healthcare sector, and #66 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$1.22BUSD
Enterprise Value
$1.11BUSD
EBITDA (TTM)
-$55.08MUSD
Net Income (TTM)
-$53.59MUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Paul LaViolette
open_in_new
Employees
75
Founded
2014
IPO
18 May 2016
Website
pulsebiosciences.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | 7.6% | 13% | -2.9% | 3.1% | 165% |
Upcoming Earnings
Earnings Date
Tue, May 6
Earnings Time
bedtime
After Close
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PLSE
Pulse Biosciences Inc
ISIN: US74587B1017
Shares Out.:
Shares Outstanding:
67.274M1
Shares Float:
12.564M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
18.18 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
